to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Tom Siebel is Chairman of First Virtual Group, a diversified holding company with interests in commercial real estate, agribusiness, global investment management, and philanthropy. Siebel was the founder, chairman, and
CEO of Siebel Systems, which merged with Oracle Corporation in January 2006. Founded in 1993, Siebel Systems became a global leader in application software with more than 8,000 employees in 32 countries, over 4,500 corporate customers, and
annual revenue in excess of $2 billion. Prior to Siebel Systems, Siebel served as CEO of Gain Technology and held various management positions at Oracle. He is a frequent industry spokesman and the author of three books, including
Taking Care of eBusiness and Cyber Rules, published by Doubleday, and Virtual Selling, published by the Free Press. Siebel is a graduate of the University of Illinois at
Urbana-Champaign, where he received a BA in history, an MBA, a MS in computer science, and a PhD with honors in Engineering.
Josh Schwarzapel is the Product Manager for Cooliris Shopping. Josh has work experience performing ﬁnancial analysis for Smith Barney, and working on a marketing team at Fox Sports. He also has substantial
non-proﬁt experience, having founded a bridge organization to connect Stanford student volunteers and Accion Emprendadora, a non- proﬁt organization in Chile that educates and provides micro-ﬁnancial
services to poor entrepreneurs.
Small and growing companies are discovering lucrative new markets abroad. Developing countries are importing products, tech know-how and system support and offering franchising, licensing and distribution opportunities. If your company is expanding abroad, you need to know what you're getting into.
Distributors, sales representatives, and cooperatives are all different venues for enabling entrepreneurial companies to sell their products and services. Understand the similarities and differences, and chose the alternative that is right for your business.
When developing a strategic plan to launch an international business program, growing companies must consider the potential barriers and adjustments they might need to make to their products and services.
Giving back to the community-and engaging one-on-one with charitable operatives, the press, and other local constituencies-enables small businesses to increase exposure at little cost, says the founder of a national moving franchiser.
Carving a niche in a specialty business entails listening to customers for specific needs and becoming known in the industry as an expert or insider, says the cofounder of a broker-dealer that serves credit unions.
Medical mobile apps will be placing patients in closer touch with their own health data, if doctors are willing to give up that control. That was one of the takeaways from a speaker at the mHealth Summit going on in Washington, D.C.
Peter A. Seligmann is one of today's most dynamic leaders in the global conservation movement, where he has brought innovation and action to the forefront of biodiversity protection for more than 25 years. In 1987, he
co-founded Conservation International, and as Chairman and CEO he has positioned CI at the cutting edge of conservation, creating lasting solutions to biodiversity and sustainable development challenges. Seligmann holds a masters degree
from Yale University's School of Forestry and Environmental Science and an honorary Doctorate in Science from Michigan State University. In 2001, he was awarded the Order of the Golden Ark from the Netherlands. Seligmann serves on the
board of the Wild Salmon Center in Portland, Oregon, and the Mayor's Environmental Council in Washington, D.C. He also serves on several corporate boards, as well as on the advisory councils of the Jackson Hole Land Trust, Ecotrust and
other not-for-profit organizations, including the Japanese Keidanren's Nature Conservation Fund. In 2000, President Clinton named him a member of the Enterprise for the Americas Board. Seligmann's work has been featured by ABC's
"Nightline," CNN and Fortune Magazine. A strong advocate of building partnerships, Seligmann has forged groundbreaking joint projects between the environmental community and other sectors, including government and industry. In 1998, CI
established the Center for Applied Biodiversity Science, and in 2001, the Center for Environmental Leadership in Business. In 2000, CI launched the Critical Ecosystem Partnership Fund in collaboration with the World Bank and the MacArthur
Foundation. Under Seligmann's leadership, CI has pioneered conservation tools that are economically sound, scientifically based and culturally sensitive. He has guided CI to become a major international conservation leader, with field
offices in more than 30 countries, and major influences
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.